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Inverse Projection Representation and Category 
Contribution Rate for Robust Tumor Recognition 
Xiao-Hui Yang, Li Tian, Yun-Mei Chen, Li-Jun Yang, Shuang Xu, and Wen-Ming Wu 
Abstract—Sparse representation based classification (SRC) methods have achieved remarkable results. SRC, however, still 
suffer from requiring enough training samples, insufficient use of test samples and instability of representation. In this paper, a 
stable inverse projection representation based classification (IPRC) is presented to tackle these problems by effectively using 
test samples. An IPR is firstly proposed and its feasibility and stability are analyzed. A classification criterion named category 
contribution rate is constructed to match the IPR and complete classification. Moreover, a statistical measure is introduced to 
quantify the stability of representation-based classification methods. Based on the IPRC technique, a robust tumor recognition 
framework is presented by interpreting microarray gene expression data, where a two-stage hybrid gene selection method is 
introduced to select informative genes. Finally, the functional analysis of candidate’s pathogenicity-related genes is given. 
Extensive experiments on six public tumor microarray gene expression datasets demonstrate the proposed technique is 
competitive with state-of-the-art methods. 
Index Terms—Tumor classification, inverse projection representation, category contribution rate, classification stability index; 
two-stage hybrid gene selection 
——————————      —————————— 
1 INTRODUCTION
ith the rapid development of gene chip technology, 
we can quickly and accurately acquire tumor gene 
expression microarray data, which have strong ability to 
measure expression levels of thousands of genes 
simultaneously. Analyzing and interpreting these gene 
data can provide aid for tumor early diagnosis on the 
level of molecular biology [1]. Therefore, effective 
analysis of microarray gene expression data techniques 
has attracted much attention in recent years. Microarray 
gene expression data, however, have the characteristics of 
small samples (patients), high dimensions (thousands of 
genes) and high redundancy [2], which impose a 
challenge to tumor classification. 
Microarray gene expression data-based tumor 
classification mainly consists of clustering [3] and 
classification [4]. For the characteristic of small sample 
size, classifier design is still an active and challenging 
issue for tumor classification [5-8]. Khan et al. [5] 
developed a method of classifying cancers to specific 
diagnostic categories based on their gene expression 
signatures using artificial neural networks. Furey et al. [6] 
used support vector machine (SVM) to analysis both 
classification of the tissue samples and give exploration of 
the data for mis-labeled or questionable tissue results. Shi 
et al. [7] proposed an improved diagonal discriminant 
analysis with sparse constraint for tumor classification. 
Liu et al. [9] proposed a tumor classification based on 
robust principal component analysis (PCA) and SVM. 
However, these methods are mostly based on statistical 
learning theory and need training process to determine 
model parameters. Recently, deep-learning based 
classification methods have been proved effective for 
recognition. However, its success usually relies on big 
data, complex net structure and advanced hardware. 
Sparse representation is a sparse coding technique 
based on an over-completed dictionary without learning. 
Sparse representation based classification (SRC) was 
originally proposed by Wright et al. for face recognition 
[10]. Xu et al. [11] proposed an integrated sparse 
representation-based face recognition method, which 
artificially enlarged training set by constructing 
symmetry virtual face samples. Our previous work [12] 
proposed an inverse projection based pseudo-full-space 
representation classification (PFSRC) for face recognition  
by focusing on exploiting complementary information 
among existing available samples rather constructing 
auxiliary training samples. Recently, SRC has attracted 
much attention from bioinformatics [13-17]. Hang et al. 
[13] applied SRC in tumor classification by interpreting 
gene expression data. Zheng et al. [14] made use of 
singular value decomposition to learn a dictionary and 
then classified gene expression data of tumor subtypes 
based on SRC. Gan et al. [15] improved and generalized 
[14] by adding a weighted matrix. Khormuji et al. [16] 
proposed a SRC based tumor classification method, 
which used geometrical structure of data. Gan et al. [18] 
used latent low-rank representation (Lat_LLR) for 
extracting salient features from the original tumor data 
before SRC. The success of SRC depends on enough 
training data of the same category. For tumor 
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classification, however, it is difficult to acquire so many 
labeled samples.  Zhang et al. [19] indicates that the 
discrimination ability of SRC will be reduced when there 
is a small disturbance on representation error. It is 
meaningful to improve the effect of tumor classification if 
one can tackle these problems of SRC. 
On the other hand, there are many irrelevant, 
redundant and noisy genes and small set of informative 
genes. It is believed that more reliable cancer 
classification results will be achieved based on the 
informative genes. Ranking methods [1, 4, 20] are 
promising and attractive because their simplicity and 
stability. Least absolute shrinkage and selection operator 
(LASSO) [21, 22] is an embedded method, which uses 
predictor performance as the objective function to 
evaluate the selected informative gene subset. Hybrid 
gene selection methods [23, 24] reach more reliable 
performance by effectively combining complementary 
strengths from different methods [25]. There are other 
methods, of course, can be used for gene selection. Wu et 
al. [26] applied sparse linear discriminant analysis to gene 
selection. Dai et al. [27] presented an attribute selection 
method based on fuzzy gain ratio under the framework of 
fuzzy rough set theory. Cadenas et al. [28] applied fuzzy 
random forest and feature selection fuzzy random forest 
with embedded capacity to tumor classification. RPCA 
technology proposed by Candes was also used for gene 
selection and achieves good results [9]. 
Motivated by these works, we propose an inverse 
projection representation classification (IPRC) to improve 
the performance of SRC based tumor classification. We 
restrict our attention to limited training samples and 
representation without learning. Here, limited training 
samples mean that there are a small number of training 
samples (with label) and others are test samples (without 
label). It is noted that the proposed inverse projection 
representation focuses on utilizing existing available 
samples to form the representation space, rather than 
constructing auxiliary samples by other ways. The main 
differences between the proposed IPRC and the related 
works [10-12] are as follows.  (1) IPRC focuses on a 
completely opposite projection way to [10] and presents a 
novel classification criterion to match the inverse 
representation and fulfill classification, which similar to 
[12]. (2) [11] also mentioned inverse representation, while 
the projection way is different because different 
applications. [11] represented each training face sample of 
a category with a test sample, training samples of the 
other categories and their symmetry virtual face samples, 
while IPRC focuses on the available test sample space. 
The classification criterion of [11] is the same with [10]. (3) 
Our previous work [12] proposed an inverse projection 
for face recognition. However, [12] projects each training 
sample into pseudo-full space because face images have 
important complementary between samples, while it not 
suitable for gene expression data. More importantly, a 
statistical measure is constructed to quantify the stability 
of representation-based classification methods. 
The remainder of this paper is organized as follows. 
The presented robust tumor classification based on 
two-stage gene selection and IPRC is stated in Section 2. 
Extensive experimental results are shown in Section 3. 
Finally, Section 4 concludes the paper. 
2 METHODOLOGY 
2.1 Inverse Projection Representation Based 
Classification 
2.1.1 Sparse Representation Based Classification 
Suppose 1[ , , ]XX x x   are training samples, Let 
X
 
be labeled training samples in total of c  categories. SRC 
[10] assumes a test sample ry  can be represented as, 
                ,
1
X
r i r i
i
y x

 ,                (1) 
where 1,2, ,i X  , 1,2, ,r k  , , r i R  is the coding 
coefficients. Let ,1 , ,[ , , , , ]
T
r r r i r X      , 1l -norm with the 
following Lagrangian formulation is often adopted. 
            22 1ˆ argmin
r
r r r ry X

      .        (2) 
The classification criterion of SRC is as follows, 
       2
2
ˆ , 1, ,jr
j
r j re y X j c     ,         (3) 
where : n nj R R  is a characteristic function that 
selects coefficients associated with the j -th category. For 
 nx R , ˆ( )j   is a vector whose only nonzero entries in 
  that are associated with category j . A test sample is 
classified into the category with the minimal 
reconstruction error. 
Next, the stability of SRC will be analyzed. Suppose 
1X , 2
m nX R  ,  which come from two different 
categories. For a sample ry  from one category, a 
coefficient vector and error can be calculated: 
2
arg mini r iy X

   and error i r i ie y X  , 1,2i  . 
Suppose the difference between 1X  and 2X  is a small 
disturbance  1 2 1X X X   , which results in ry  has a 
small disturbance  ry .  The error can be calculated 
     
 
11 2 2
1 1 12 2
max , r X
r
XX y
X y X



     
  
,       (4) 
where  1 1X  and  1X X  are the largest and the 
smallest singular values of 
1X , respectively. Refer to [19], 
the relationship between ,1re  and , 2re  
can be written as, 
      ,2 ,1 22 2 1
2
1 min 1,r r
r
e e
X m n O
y
  

    ,     (5) 
where   12 1 1 2 1 1 1 2|| || || ( ) ||T TX X X X X   is the 2l -norm 
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conditional number of 
1X . It is obviously that the bigger 
the similarity of 1X  and 2X  is, the smaller the 
difference between ,1re  and , 2re  is. Eq. (5) 
demonstrates that misclassification is easy to happen and 
the classification is unstable when ,1re  is similar to , 2re . 
2.1.2 Inverse Projection Representation 
Suppose there are few training samples (with label) per 
category, and the others are test samples (without label). 
In this case, SRC doesn’t work well. Therefore, an IPR is 
proposed to obtain a more stable representation by 
exploring test sample space. 
  The projection way of IPR is opposite to that of sparse 
representation. Let 1[ , , ]kY y y   is test sample space, 
where k  expresses the number of test samples. Each 
training sample ix  can be represented by all test 
samples. 
           ,1 1 , ,...i i i r r i k kx y y y       ,           (6) 
where ,i r R  are representation coefficients. Let 
,1 ,[ , , ]i i i k      represents coefficient vector, ix  can be 
rewritten as .i ix Y   And then all training samples 
1[ , , ]XX x x   can be linearly represented as follows. 
                    X Y ,                   (7) 
where 1[ , , ]X     is the coefficient matrix. 
Zhang et al. [19] indicates that it is the collaborative 
representation, but not sparsity, that plays the essential 
role for classification in SRC. Moreover, it is also proved 
that the 1l -norm can be replaced by 2l -norm, which can 
achieve similar classification results but with significantly 
lower complexity. Therefore, 2l -regularized constraint is 
used in IPR model. 
 2 22 2ˆ arg min
i
i i i ix Y

      ,          (8) 
where   is a regularization parameter. 
The analytic solution of matrix form ˆ  with 
regularized least square about Eq. (7) is easily and 
analytically derived as  
1ˆ ( )Y Y I Y X     .             (9) 
As a result, IPR can be more easily implemented than 
standard sparse representation. What we emphasize is 
that, the representation space may be enlarged by using 
test samples, especially there are a small number of 
training samples per category. 
It is easy to notice that the latter focuses on the column 
coefficients before test samples, rather than row 
coefficients of training samples for the former. The 
different projection way makes the IPR is less sensitive to 
the number of training samples than that of sparse 
representation. 
The feasibility of the proposed IPR can be further 
analyzed as follows. Similar to [19], for the simplicity of 
analysis, the regular term in Eq. (8) is removed and then 
the representation becomes a least square problem, 
2
2
ˆ argmin
i
i i ix Y

   . 
 Let jix  represent a training sample ix  belongs to 
category j , which can be represented by the test sample 
space based on IPR. Similar to standard sparse 
representation and without cause confusion, suppose jY  
denotes test sample subspace belong to the same category 
with ix , the associated representation ˆˆ ( )j ji j i
j
x Y    is 
actually the perpendicular projection of ix  onto the test 
sample full space Y . The reconstruction error by each 
category   22ˆ|| ||j jj i j ie x Y     is used for classification. It 
can be readily derived by 
   2 2 22 2 2ˆ ˆˆ ˆ|| || || || || ||j j j j j jj i j i i i i j ie x Y x x x Y         . 
Obviously, it is the amount   22ˆˆ|| ||j jj i j ie x Y      that 
works because 22ˆ|| ||
j j
i ix x  is a constant for all categories. 
Denoted by  ˆjj j iY   and  ˆ ˆmj m i
m j
Y  

 , 
1, ,m c  , m j , since ˆ j is parallel to  ˆˆ j ji j ix Y   , 
we can readily have 
  22 ˆˆ|| ||ˆ|| ||
ˆ ˆsin( , ) sin( , )
j jj
i j ii
j
j j j i
x Yx
x
 
  

= , 
where ˆ( , )j j  is the angle between j  and 
ˆ j , and 
ˆ( , )jj ix is the angle between j and ˆ
j
ix . Finally, the 
representation error can be represented by 
 
2 2
22
2 2
ˆ ˆsin ( , ) || ||
ˆˆ|| ||
ˆsin ( , )
j j
j i ij j
j i j i
j j
x x
e x Y

 
 
    .       (10) 
Eq. (10) shows that by using IPR, when judging if jix
has a strong correlation with a test sample, we need not 
only consider if ˆsin ( , )jj ix is small and also consider if 
ˆsin ( , )j j   is large. Such a “double checking” makes the 
representation effective and robust.  
2.1.3 Category Contribution Rate 
It can be observed that the conventional classification 
criteria, reconstruction error, doesn’t work for IPR. Since 
the representation dictionary is unlabeled test samples. 
Hence, a classification criterion, CCR, is constructed to 
match the proposed IPR and complete classification, 
which is called IPRC. 
Definition 1 (Category Contribution Rate, CCR) For a 
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test sample ry , the contribution rate ,j rC  of ry  for the 
j -th category can be calculated by Eq. (11). 
  
 
,
,
,
1 , 1, ,
j i r
j r
ij i r
i
C i X
s
 

 
   
  
 
 ,       (11) 
where 1,2, ,j c  , 1,2, ,r k  , js denotes the number 
of j -th category training samples. For eliminating 
effects of training sample size may differ in different 
categories, the projection coefficient vector of every 
category before ry  is normalized by summing up itself 
and solving the average. And then the CCR matrix 
,[ ]j rC , 1, ,j c  , 1, ,r k   for all test samples is got. 
The larger the CCR is, the higher the correlation 
between each test sample and every category is. A test 
sample ry  is classified into the category with the 
maximal contribution rate. 
,
{1, , }
arg max( )r j r
j c
m C



.               (12) 
By this means, categories of all test samples are 
obtained simultaneously and classification can be 
completed. 
Comparing Eqs. (3) and (11), one can see that the 
difference between reconstruction error and CCR lies in 
that the latter focuses on the coefficients before each test 
sample rather than the former focuses on those of training 
samples. Experiments will be shown in Subsection 3.3.2. 
2.1.4 Stability Analysis of IPRC 
Theorem (Classification Stability of IPRC)    Suppose
,i jx x  are i -th and j -th training samples, and the relationship  
ix  and jx  is  j i ix x x  , where  ix  is a  
disturbance of ix . Based on the test samples Y , the IPRs of 
,i jx x are as follows: i ix Y , j jx Y , where i  and j  
are representation coefficients for ix  and jx , respectively. Let 
 Y  represents the disturbance corresponding to  ix . If 
     
 
2 2
12 2
max ,i k
i
x Y Y
x Y Y


     
  
, 
and   2sin / 1LS ix   , where 2|| ||iLS LS iY x   , 
2argmin || ||i
i
LS i ix Y

   , then 
   22 22 2
2
|| || 2 ( ) tan ( ).
|| || cos( )
j i
i
Y Y O
     
 
     
      
 (13) 
where 2 ( )Y  ( 12 2 2( ) || || || ( ) ||T TY Y Y Y Y   , 
2 2 1
2 2 2( ) || || || ( ) ||
TY Y Y Y   ) is the 2l -norm conditional 
number of Y , and   is angle between ix  and its projection 
vector on Y . 
Proof. In order to discuss the value of 2
2
|| ||
|| ||
j i
i
 

 , we need 
to find the relationship between i  and j . Let   i t   
is continuously differentiable for all [0, ]t  , where 
 0i i   and  j i   . Let  i t  do the Taylor 
expansion at 0t  : 2( ) (0) (0) ( )i i it O t      . We have 
2(0) ( )ij i O       when t  . Then 
   2 2 2
2 2
|| || || 0 ||
|| || || ||
j i i
i i
O
   
 

  .          (14) 
In order to obtain   2|| 0 ||i , similar to Theorem 5.3.1 in 
[29], one can construct      iY tf Y tf t  , where
  /f Y  , then 
           ( / )i i iY tf Y tf t Y tf x t Y t         . 
Let   /iE x  , then 
         i iY tf Y tf t Y tf x tE      .        (15) 
In order to bound   2|| 0 ||i , one can take the derivative 
of Eq. (15) and set 0t  , (0)=T T Ti i if Y Y f YY      
T T
iY E f x  i.e., 
         1 10i i i iY Y Y E f Y Y f x Y           .  (16) 
By singular value decomposition theorem [29], we have 
 rank Y tf k   for all  0,t  , where     
2 k
Y Y 
(  k Y  is the largest singular value of Y ).  Then 
   2 2 2|| || || / || || || ,kf Y Y Y      
and  2 2 2|| || || / || || ||i iE x x   . 
By substituting Eq. (16) result into Eq. (14), taking 
norms, the inequality can be obtained, 
 
2 1 2
22
2 2 2
2 1 2
22
2 2
|| || || |||| ( ) || 1
|| || || || || ||
|| ( ) ||
|| || || ||
j i T i
i i
LS
i
xY Y Y Y
Y
Y Y Y O
Y
 

 
 

 
 
       
  

   

. 
Since ( ) 0TY Y xi i   , Y i  is orthogonal to Y xi i  , 
it is also known that 2 2 22 2 2|| || || || || ||i i i ix Y Y x    , then 
2 2 2 2
2 2 2|| || || || || ||i i LSY x    .  
The relationship between i  and j  will be 
   22 22 2
2
|| || sin1( ) 1 ( ).
|| || cos( ) cos( )
j i
i
Y Y O
     
  
         
     
The conclusion indicates that the distance between i  
and j  is very small when ix  is similar to jx (in other 
words, Y  has a small disturbance ( )Y ). Compared Eq. 
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(13) with Eq. (5), one can see that coefficients are more 
sensitive to a small disturbance   than that of 
reconstruction error. Because, for nonzero residual 
problems, it is the square of the condition number that 
measures the sensitivity of coefficients. In contrast, 
according to Subsection 2.1.1, reconstruction error 
sensitivity linearly depends on the condition number 
2 1( )X . Moreover, it is worth noting that we focus on the 
column coefficient vector 1,1 1,2 ,1, , , X      before each test 
sample when we calculate CCR. However, it has been 
demonstrated that disturbance will affect row coefficients 
rather than column coefficients. Moreover, the effect on 
column coefficients is a positive impact when CCRs of 
different categories are calculated. 
For further quantifying the classification stability of 
representation-based methods, we propose a statistic 
measure named as CSI. 
Definition 2 (Classification Stability Index, CSI) For the 
representation-based classification methods, suppose 
1
bestR  and 
2
bestR  are the values of a classification criterion 
corresponding to the best category and the second best 
category. The CSI of a test sample is defined to measure 
the difference between 1bestR and 2bestR . The CSI is 
normalized as [0,1]CSI   and is always defined as the 
ratio of the smaller one and the larger one. 
1 2/ .best bestCSI R R  
For SRC, the CSI is denoted as RECSI , where 1bestR  and 
2
bestR  are the minimal reconstruction error and the second 
minimal one. While for IPRC, the CSI is denoted as 
CCRCSI , where 1bestR  and 2bestR  are the second maximal 
CCR and the maximal one. The smaller the index is, the 
better the stability is, the better the representation-based 
method is. Experiments will be shown in Subsection 3.3.3. 
2.2 TWO-STAGE HYBRID GENE SELECTION 
A two-stage hybrid gene selection method is presented to 
extract informative genes and to further improve the 
performance of IPRC for tumor classification. 
2.2.1 The First Stage-Gene Pre-selection 
The first stage, gene pre-selection, aims to primarily select 
information genes by top-ranked intersection of three 
filter methods, analysis of variance, ANOVA) [20], signal 
noise ratio (SNR) [1] and the ratio of between-groups to 
within-groups sum of squares (BW) [4].  
{ } { } { }f ANOVA SNR BWG G G G   , 
where fG  is the gene subset based on the first stage, 
ANOVAG , SNRG  and BWG  are the gene subsets based on 
analysis of variance, SNR and BW, respectively. 
This step primarily picks up candidate genes and 
reduces the computational complexity. Without loss of 
generality, the significance level 0.05p   is selected   
for ANOVA. 
2.2.2 The Second Stage-Gene Refinement 
The second stage, an embedded approach, 
LASSO-logistic regression [22] is used to perform the 
gene refinement, which further efficiently refines the 
smaller subset of candidate information genes.  
     0
0
0 0, 1 1
ˆ ˆ, arg max log 1 i
N d
x
i i j
i j
y x e  
 
      
 
        , 
where ix  and iy  express the gene expression data and 
the label of i -th sample respectively, and   denotes 
regression coefficient vector and is designed to cope with 
the case that y  follows multinomial distribution. 
The penalty parameter   in LASSO is selected 
corresponding to the best classification accuracy on the 
training set by ten-fold cross-validation. The LASSO 
model is trained on nine-fold of training set, while the 
validation is conducted on the other fold training set. 
It is worth noting that LASSO is introduced to select 
gene subset which is used to subsequent classify, that is, 
the quality of gene subset depends on the classification 
effect. Therefore, the parameters are selected based on the 
classification effect rather than those selected by LASSO 
itself. That is to say, the validation is based on the 
classification results, which is based on the gene subset 
selected from the trained LASSO model. 
First of all, we do ten-fold cross validation on the 
training set, and give the average error of ten folds as 
cross-validation error, 
10
,
1
1 ,
10i i jj
Error err

   
where iError  is the cross validation error of the 
parameter i , and ,i jerr , 1, ,10j   is the verification 
error of every fold. It should be noted that the verification 
error is the classification error on the verification set (that 
is, the other fold training set). 
Then, the parameter ˆ  corresponding to the 
minimum cross-validation error *Error  is selected as the 
final parameter of LASSO,  
1{ , , }
ˆ argmin ( ).
i N
iError
  




 
The gene subset corresponding to the parameter is just 
the one used for classification. 
For the selected parameter ˆ , the corresponding gene 
subsets , 1, ,10jG j    obtained by ten folds are not 
exactly the same. Therefore, we compare each fold gene 
subsets, and finally chose the one corresponding to the 
minimum error, 
1 10
*,
{ , , }
ˆ arg min ,
j
j
G G G
G err



 
where *, jerr  is the verification error for each fold. 
2.2.3 Two-Stage Hybrid Gene Selection 
The reasons of using two-stage hybrid gene selection 
method which combined filter method with embedded 
method are as follows. Filter method can provide general 
solutions for various classifiers because it is independent 
of any learning algorithm. However, filter methods ignore 
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the interactions between classifiers and may not be 
suitable for all classifiers. Embedded methods, to some 
extent, can solve the problems of the filter approach by 
considering the dependencies on features and classifiers. 
However, the computational complexity is a major issue, 
especially can be intractable for large datasets. As the 
filter method efficiently reduces the size of the gene set, 
the computational complexity of embedded method 
becomes acceptable and two methods bring out the best 
to each other. The framework of the two-stage gene 
selection method is shown in Fig. 1. 
2.3 TUMOR CLASSIFICATION BASED ON 
TWO-STAGE HYBRID GENE SELECTION 
AND IPRC 
Combined the two-stage hybrid gene section with IPRC, 
the basic idea of our robust tumor classification algorithm 
is as follows. 
Input: Training sample set 1 2, , , XX x x x    , training 
label set 1 2= , , , XL l l l    and test sample set 
 1 2= , , , kY y y y . 
Preprocessing: Standardize the observations (arrays) to 
have mean 0 and variance 1 across variables. Two-stage 
hybrid gene selection is applied to   , , 1, ,i ix l i X  and 
then is applied to Y . And we get samples only with 
informative genes. 
Classification based on IPRC: 
Step1. By Eq. (6), the IPR is realized. 
Step2. By Eq. (9), the projection coefficient matrix is got. 
Step3. By normalizing the CCR matrix, relevancies 
between each test sample and all categories are 
obtained. 
Output: By Eq. (12), each test sample can be classified into 
the category with the maximal CCR. 
Identification of pathogenic genes: Based on the 
two-stage hybrid gene selection, the informative genes are 
selected as the candidate pathogenic subset, whose 
occurrence number is more than a threshold value. 
Fig. 2 shows the framework of IPRC with two-stage 
hybrid gene selection for robust tumor classification. 
3 RESULTS 
Experiments are demonstrated on six public gene 
expression datasets. Six kinds of measures are used to 
measure the performance of these methods. Accuracy 
measures the classification performance by using the 
percentage of correctly classified samples. Sensitivity 
measures the non-missed diagnosis performance by using 
the rate of correctly classified positive samples. Specificity 
measures the non-misdiagnosis performance by using the 
rate of correctly classified negative samples. For any test, 
there is usually a trade-off between the sensitivity and 
specificity. This tradeoff can be represented graphically 
using a receiver operating characteristic curve (ROC), 
which is a graphical plot that illustrates the diagnostic 
ability of a binary classifier system as its discrimination 
threshold is varied. AUC is just the area under the curve 
of ROC and is also suitable to binary classification 
problem [30]. Error reduction rate (ERR) [31] intuitively 
characterizes the proportion of the errors reduced by 
switching a method to the other one. Without loss of 
generality, ten-fold cross-validation ten times is used to 
test the performance of the algorithms. All experiments 
are carried out using MATLAB R2016a on a 3.30GHz 
machine with 4.00GB RAM. 
3.1 Tumor Data Sets 
Six public benchmark cancer microarray gene expression 
datasets are used to evaluate the performances of our 
methods: Colon [32], DLBCL [33], SRBCT [5], 9_Tumors 
[34], 11_Tumors [35] and Leukemia [36]. The first two are 
binary category datasets and the remaining four are 
multi-categories datasets. Colon dataset consists of gene 
expression data of 40 tumor and 22 normal colon tissue 
samples. The number of genes is 2000. DLBCL dataset 
consists of gene expression data of diffuse large B cell 
lymphoma, follicular lymphoma. There are 77 samples, 
each of which contains 5469 genes. SRBCT dataset 
consists of small, round blue cell tumors (SRBCT) of 
childhood. There are 2308 genes in each sample and 83 
samples. 9_Tumors dataset consists of gene expression 
data of nine different human tumor types, such as 
 
Fig. 2. Flowchart of the two-stage hybrid gene selection and IPRC 
for robust tumor classification.  
 
 
Fig. 1. Flowchart of the two-stage hybrid gene selection. 
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NSCLC, colon and breast, including 60 samples. Each 
sample has 5726 genes. 11_Tumors dataset consists of 
gene expression data of eleven different human tumor 
types, such as ovary, breast and colorectal. There are 
12533 genes in each sample and 174 samples. Leukemia 
dataset consists of gene expression data of acute 
myelogenous leukemia, acute lymphoblastic leukemia 
and mixed-lineage leukemia, including 72 samples. Each 
sample has 11225 genes. 
3.2 Parameters selection 
3.2.1 Parameter of LASSO Model 
Fig.3 gives the cross validation error at different values of 
parameter   on Colon dataset. The abscissa is the 
number of selected genes, and the ordinate is the 
cross-validation error. Points on the curve represent 
parameter values of  . The dotted arrow and the solid 
arrow corresponding to the parameters selected by 
LASSO itself and our proposed method, respectively. 
Fig. 3 shows that the final selected parameter 
ˆ 1.20 - 4e   and the number of genes is 143. It is worth 
noting that the parameter selected by LASSO itself is 
6.73 - 2e , and the corresponding gene subset has higher 
cross-validation error and lower classification accuracy. 
That is to say, the parameter selected by LASSO itself is 
not the one we want, because it doesn’t get the best 
classification results. Similarly, Fig.4 gives the results on 
DLBCL dataset, where the parameter of LASSO is 
ˆ 6.80 - 5e   and the number of selected genes is 270. 
Without loss of generality, if multiple folds (greater 
than one fold) have the same lowest error, one can choose 
any of them. In this paper, we further calculate the 
entropy of each fold of gene subset, and select the one 
corresponding to the lowest entropy. The reason for that 
is entropy means uncertainty, and the greater the entropy 
is, the greater the uncertainty is. Fig.6 shows that the 
validation errors (Fig. 5(a)) and entropies (Fig. 5(b)) of 
each fold on Colon dataset, where the selected parameter 
is ˆ 1.20 - 4e  . The gene subset of the fifth-fold is 
selected as the final selected gene subset because it has 
the minimum verification error and entropy. 
3.2.2 Parameter of Inverse Projection 
Representation Model 
By using the method described in Subsection 2.3, we 
firstly randomly separate the six datasets into training set 
and test set. In all experiments, the regularization 
parameter   is set to /n m  in Eq. (8), where n  and m  
are the numbers of test samples and training samples, 
respectively. On the one hand, the parameter setting is 
similar to PFSRC [12] and CRC [19]. On the other hand, 
the regularization parameter   is tested by experiments. 
Taking binary category dataset (Colon) and 
multi-category dataset (Leukenmia) as examples, the 
regularization parameter   are set to 0.0001* /n m , 
0.001* /n m , 0.01* /n m , 0.1* /n m , 2* /n m , 3* /n m  
and /n m , respectively. We select the parameter value 
corresponding to the optimal classification accuracy. Fig. 
6 shows that /n m   is clearly better than the others. 
3.3 Results of Tumor Classification Based on IPRC 
In this subsection, the performance of the proposed IPRC 
method is demonstrated. The comparable methods are 
SVM, SRC and some improved SRC methods. SVM is 
chosen because SVM [37-38] outperform K-nearest 
   
(a)                       (b) 
Fig. 5. Classification results of each fold on Colon dataset, (a) 
error rate, (b) entropy.  
 
 
Fig.3. The numbers of genes and average error rate
corresponding to different penalty parameters   on Colon 
dataset. 
 
 
Fig. 6. Comparison of classification accuracy based on different 
regularization parameter values. 
 
 
Fig.4. The numbers of genes and average error rate 
corresponding to different penalty parameters   on DLBCL 
dataset.. 
 
 
Fig. 7. Comparison of accuracies with decreasing training 
samples per category. Curves of accuracy versus number of 
training samples per category on (a) Leukemia dataset and (b)
11_Tumors dataset. 
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neighbors and neural network in gene expression cancer 
diagnosis [35]. Although we mainly focus on the 
proposed projection way and classification criterion, it is 
believed that improved strategies in SRC methods also 
can be embedded in our IPPC framework. 
3.3.1 Comparison of Inverse Projection 
Representation and Sparse Representation 
By taking full advantage of the information embedded in 
test samples, the IPR can relieve the problem of 
insufficient training samples. The performance of 
standard representation and the proposed IPR are 
compared by reducing the number of training samples 
per category. In order to verify the stability, we perform 
on two different categories distribution datasets. The 
Leukemia dataset has a balanced distribution on all 
categories of sample number, while 11_Tumors has a 
badly unbalanced sample. For dataset with balanced 
distribution, the number of training samples per category 
is reduced from 10 to 2 in Fig. 7 (a). While for dataset with 
unbalance distribution, the percentage of training sample 
number per categories is decreased from 70% to 25% in 
Fig. 7 (b). From Fig. 8, it can be seen that SRC and IPRC 
reach similar results when the number of training 
samples is more than 6 per category or percentage is more 
than 45%. With decreasing the amount of training 
samples, classification accuracy of SRC will soon lower 
than IPRC. The results show that IPRC performs more 
stable than SRC, especially when there are few training 
samples.  
For testing the performance of the proposed IPRC 
model when the test data is not balanced in each category, 
the experiments on binary category dataset and 
multi-category are done. Without loss of generality, 
binary category dataset (Colon) and multi-category 
dataset (Leukenmia) are selected as examples. We fix the 
number of test samples in one category and change that 
of another category from more to none (zero). 
Experiments are given in the Fig. 8, which shows that: (1) 
the category-imbalance does affect the classification 
results, and the classification accuracies of 
category-balance is superior to category-imbalance. (2) 
the optimal classification accuracy is achieved when the 
numbers of samples are balanced. (3) IPRC has higher 
accuracies and better stability than SRC either 
category-balance or category-imbalance. 
3.3.2 Comparison of Category Contribution Rate 
and Reconstruction Error 
For verifying the CCR has discrimination power for 
tumor classification, we randomly select some test 
samples and calculate the corresponding CCR results 
across all categories. Some individuals of 11_Tumors are 
randomly taken as examples, nine test samples (55th, 29th, 
116th, 21th, 159th, 66th, 106th, 59th and 131th samples in 
order) on 11_Tumors dataset. Fig. 9 gives the CCR results 
of these test samples versus all categories. It can be seen 
that there is only one peak (the maximum CCR) in every 
subfigure obviously, which means that we can judge the 
category of a test sample based on the maximum CCR. 
Next, it is demonstrated CCR for IPRC is superior to 
reconstruction error for SRC. It’s worth noting that the 
more obvious the difference between categories is, the 
stronger the discrimination ability is, and the better the 
classification criterion is. Figs. 10 and 11 give the results 
of the two criterions about some randomly selected test 
samples in binary category (Colon) and multi-category 
(11_Tumors) datasets, respectively. The same color 
 
(a)                          (b)  
Fig. 8. Comparison of classification accuracies when the test data 
is not balanced in each category. (a) Colon dataset, (b) 
Leukenmia dataset. 
 
 
Fig. 11. The comparison on 11_Tumors dataset. (a) CCR (b) 
Reconstruction error. This 3-dimensional histogram shows the 
values of two classification criterions of test samples across all 
classes. The same color expresses the values of the same test 
sample across all categories. 
 
Fig. 9. Curves of CCR versus all categories about nine test 
samples on 11_Tumors dataset. Test samples will be classified 
into the category with the only peak. 
 
 
Fig. 10 The comparison of seven samples random selected on 
Colon dataset. (a) CCR (b) Reconstruction error. The same color 
histogram expresses the same category. 
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expresses the values of a test sample across all categories. 
According to the overall trend, one can see that, to the 
same test sample, difference between categories of CCR is 
much bigger than that of reconstruction error. This shows 
that the CCR has better discrimination power than 
construction error. Moreover, for example, the CCR 
classifies the sixth test sample in Fig. 10 easily, but 
reconstruction error is hard to discriminate and leads to a 
wrong classification. The classification stability will be 
further verified in the following Subsection. 
3.3.3 Results of Classification Stability 
The classification stability is further verified by 
comparing the quantitative indicator of stability, CSI. 
Fig.12 shows the CSI of all samples on the six datasets 
(Colon, DLBCL, SRBCT, 9_Tumors, 11_Tumors and 
Leukemia in order). The smaller the CSI is, the better the 
stability is. One can see that RECSI  is almost close to 1 in 
all subfigures, while the CCRCSI  is much smaller. That is 
to say, the difference between 1bestR and 
2
bestR  in CCR for 
IPRC is much bigger than those in reconstruction error for 
SRC. This further verifies CCR for IPRC has better 
discrimination ability than reconstruction error for SRC.   
3.3.4 Results of IPRC-Based Tumor Classification 
The performance of IPRC for robust tumor classification 
is demonstrated in this subsection. For comparison, the 
results of SVM and SRC are listed under the same 
experimental environment. For each experiment, we run 
the ten-fold cross validation ten times and take the means 
as the final results. 
 Table 1 and Fig.13 show that IPRC achieves competitive 
results with highest AUC, which shows IPRC has the best 
prediction ability among the three classifiers. ROC plot 
analysis in Fig. 13 has shown that IPRC has the better 
discrimination ability than SVM and SRC. The accuracy 
and sensitivity of IPRC are higher than SVM and SRC on 
Colon dataset. Especially sensitivity of IPRC is 14.77% 
higher than SVM and SRC, that is, the missed diagnosis 
rate of IPRC is the lowest. Although the specificity is 
slightly lower than SVM and SRC. It is worth noting that 
the patients with acute abdominal pain as main 
symptoms are susceptible to missed diagnosed in clinical 
treatment. Hence, high sensitivity and low missed 
diagnosis rate are indeed needed and helpful for early 
clinical diagnosis. For DLBCL dataset, the patients will 
face multiple courses of chemotherapy and great 
psychological stress if follicular lymphoma is 
misdiagnosed as diffuse large B-cell lymphoma. 
Therefore, we want to reduce misdiagnosis as far as 
possible. IPRC just has the specificity of 100%, which 
means the rate of misdiagnosing follicular lymphoma as 
diffuse large B-cell lymphoma is 0%. For multi-categories 
datasets, Table 1 shows IPRC is superior to SVM and SRC. 
Moreover, one can also observe that the two sparse 
representation-based methods, SRC and IPRC, have 
higher sensitivity and specificity than SVM. As for the 
acceptable level of accuracy, sensitivity and specificity for 
a given disease depend on clinical context. For instance, 
the accuracies of the Colon dataset are 82.73%-90.91%, the 
AUCs of the same dataset are 84%-93% [9]. Dettling et al. 
[39] demonstrated similar levels of accuracy of 87.1%. 
García-Nieto et al. [40] give the sensitivity and specificity 
of 85.93% and 83.89%. Dang et al. [41] got the sensitivity 
and specificity of 81.82% and 90.95%. Consequently we 
TABLE 1 
CLASSIFICATION RESULTS ON SIX DATASETS 
Methods Accuracy Sensitivity Specificity AUC 
Colon dataset 
SVM 85.48 72.73 92.50 0.8080 
SRC 85.48 72.73 92.70 0.8455 
IPRC 88.81 87.50 90.90 0.9250 
DLBCL dataset 
SVM 94.09 98.28 89.47 0.8721 
SRC 94.75 98.28 94.74 0.9537 
IPRC 89.82 91.37 100 0.9855 
9_Tumors dataset 
SVM 65.10 33.33 92.16 - 
SRC 66.67 33.33 92.16 - 
IPRC 66.67 44.44 94.11 - 
11_Tumors dataset 
SVM 94.68 92.50 95.80 - 
SRC 94.83 92.59 95.92 - 
IPRC 95.00 93.10 96.27 - 
Leukemia dataset 
SVM 96.60 94.74 94.12 - 
SRC 95.83 94.74 94.06 - 
IPRC 96.90 96.43 97.73 - 
SRBCT dataset 
SVM 100 100 100 - 
SRC 100 100 100 - 
IPRC 100 100 100 - 
 
 
Fig. 12. The curve of CSI versus all samples in ten-fold cross 
validation. The star line expresses CSIs of CCR in IPRC, and 
square line expresses CSIs of reconstruction error in SRC. 
 
 
Fig. 13 ROC analysis of the ability of SVM, SRC and IPRC on Colon 
and DLBCL datasets. Note that on the vertical axis, the scale is from 
no (0) to complete (1 or 100%) sensitivity. The horizontal axis is a 
reciprocal scale (1-specificity). The optimum performance of a test is 
determined either as the highest sum of the specificity and sensitivity 
or at an acceptable level of sensitivity for the given disease. 
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can draw the conclusion that the results of IPRC are in the 
acceptable range. 
More intuitively, ERR [31] is introduced by denoting a 
notion ↓. Table 2 lists the ERR results by switching SRC to 
IPRC on Colon, 11_Tumors, Leukemia and 9_Tumors 
datasets. Since the accuracy on SRBCT dataset is 100% for 
all classifiers, the ERR need not to be calculated. For 
DLBCL dataset, the ERR doesn’t also need to calculate 
because the classification accuracy is slightly lower than 
SRC. For instance, since the IPRC reduces the error rate 
from 14.52% to 11.19%, the ERR is 22.93% 
[(14.52-11.19)/14.52], suggesting that 22.93% recognition 
errors can be avoided by using IPRC instead of SRC. 
From all these results, one can conclude that IPRC 
method is feasible and effective for not only binary tumor 
classification problems but also multi-category tumor 
classification problems. The reason for IPRC is superior to 
SVM and SRC may due to the following two facts. Firstly, 
the number of training sample is small, while SRC and 
SVM do not consider the information embedded in test 
data. Secondly, the CCR is more stable to a small 
disturbance than reconstruction error, which has been 
validated in Subsections 3.3.2 and 3.3.3. 
3.3.5 Results of Comparing with Some Improved 
SRC Methods 
The performance of IPRC is also compared with those of 
some recent SRC-based methods, SRC_Lat_LRR [18], 
LLE+SR [16], MRSRC [15] and MSRC-SVD [14]. It is worth 
noting that these compared methods combine SRC with 
some relatively complex techniques. The classification 
accuracies of 9_Tumors and 11_Tumors datasets are listed 
in Table 3, which shows IPRC achieves competitive 
results and is somewhat slightly higher than MSRC and 
MRSRC for 9_Tumors dataset. The average classification 
time over 10 runs of IPRC and SRC are shown in Table 4. 
Compared with SRC, IPRC needs much less time. Tables 3 
and 4 show that IPRC leads to competitive classification 
results with simple model and low computational 
complexity. 
3.4 Results of Tumor Classification Based on 
Two-Stage Gene Selection and IPRC 
Classification results of IPRC with and without gene 
selection are given in this section. Since the accuracy on 
SRBCT dataset is 100% for all the classifiers, we do the 
experiments on the other five datasets. 
Firstly, we illustrate the necessity of gene selection. 
Corresponding to Table 1, Table 5 gives classification 
results based on BW gene pre-selection method and our 
TABLE 5 
CLASSIFICATION RESULTS ON FIVE DATASETS 
 (WITH GENE SELECTION) 
Methods Accuracy Sensitivity Specificity AUC 
Colon dataset 
SVM with BW 87.10 77.27 92.50 0.7273 
SRC with BW 87.10 81.82 90.00 0.8852 
IPRC with BW 90.48 87.50 90.90 0.8841 
IPRC with first stage 90.95 92.50 90.90 0.9523 
DLBCL dataset 
SVM with BW 94.40 96.55 89.47 0.9029 
SRC with BW 94.75 98.28 94.74 0.9610 
IPRC with BW 93.75 91.37 100 0.9819 
IPRC with first stage 94.82 92.25 100 0.9846 
9_tumors dataset 
SVM with BW 66.82 33.33 94.12 - 
SRC with BW 68.21 40.00 96.42 - 
IPRC with BW 66.82 44.44 97.73 - 
IPRC with first-stage 73.55 44.44 98.09 - 
11_tumors dataset 
SVM with BW 95.00 92.50 96.29 - 
SRC with BW 94.91 92.59 95.92 - 
IPRC with BW 95.96 96.29 99.31 - 
IPRC with first stage 96.18 96.29 99.31 - 
Leukenmia dataset 
SVM with BW 97.22 97.37 94.12 - 
SRC with BW 96.42 97.06 94.72 - 
IPRC with BW 98.33 97.73 100 - 
IPRC with first stage 98.75 97.73 100 - 
 
TABLE 3 
 ACCURACY OF DIFFERENT METHODS ON 9_TUMORS AND 
11_TUMORS  
Experiments Methods Dataset 
9_Tumors 11_Tumors 
Our methd IPRC 66.67 95.00 This paper IPRC 66.67 95 
Gan et al.(2014) SRC_Lat_LRR 66.67 94.83 
Khormuji et LLE+SR 66.75 96.42 
Gan et al.(2013) MRSRC 60.00 95.40 
Zheng et al.(2011) MSRC-SVD 63.33 95.98 
 
TABLE 4  
AVERAGE CLASSIFICATION TIME ON SIX DATASETS 
 Colon DLBCL 9_tumors 11_tumors Leukemia SRBCT 
SRC 0.6556 3.8659 2.4286 25.1199 5.2407 1.0906 
IPRC 0.0011 0.0022 0.0045 0.0270 0.0037 0.0019 
TABLE 2  
COMPARATIVE ERROR RATES ON SRC AND IPRC 
Datasets 
Error Rate (%) 
ERR 
SRC IPRC 
Colon 14.52% 11.19%  22.93% 
11_Tumors 5.17% 4.02%  22.24% 
Leukemia 4.17% 3.10%  25.66% 
9_Tumors 33.33% 33.33%  0 
 
Fig. 14. ROC analysis of the ability of SVM with BW gene 
pre-selection, SRC with BW gene pre-selection, IPRC with BW 
gene pre-selection and IPRC with first-stage hybrid gene selection 
on Colon and DLBCL datasets. The vertical axis is sensitivity. The 
horizontal axis is 1-specificity. 
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two-stage hybrid gene selection method on five datasets. 
From Table 5, one can see that BW method plays a 
positive role on all methods. On DLBCL dataset, BW gene 
pre-selection improves the performance of SVM obviously, 
but achieves a little improvement on SRC and IPRC. The 
proposed two-stage hybrid gene selection method can 
further improve the performance of IPRC, especially for 
multi-category datasets. Fig. 14 gives the ROC 
corresponding to Table 5. 
Next, the performance of the IPRC based on the 
proposed two-stage hybrid gene selection will be 
demonstrated on Colon and DLBCL datasets. Table 6 
gives the classification results. There are two reasons for 
only discussing binary-category classification at LASSO 
-based gene refinement stage. One is the advantage of 
IPRC on multi-category datasets has already been proved 
in Table 5. The other is the fact that Zhang et al. [42] 
shows that LASSO for multi-category of genetic selection 
faces great difficulties. Table 6 shows that the 
classification accuracy increases with decreasing the 
number of information genes, when we perform the 
proposed two-stage gene selection. 
Next, the performance of gene selection is visualized 
using principal component analysis. Fig. 15 represents 62 
samples consisting of 40 Colon tumor (stars) and 22 
normal (squares) using the top three principal 
components of total 2000 genes, 389 genes based on BW 
gene selection method and 143 genes based on the 
proposed two-stage hybrid gene selection method 
respectively. Fig. 15 (a) shows that a few of the 2000 genes 
provide classification information and the distribution 
just looks uniform in each direction. Fig. 15(b) shows that 
the 389 genes can mostly separate different cancers. Fig. 
15(c) also shows the 143 genes have the best separability 
than those of Figs. 15 (a) and (b). All this suggests that the 
informative genes based on the two-stage method contain 
the main classification discriminant information. 
Compared with [9], experiments are conducted on 
Colon and 11_Tumors datasets. In Colon, the IPRC with 
two-stage hybrid gene selection (91.90%) performs better 
than the RPCA+LDA+SVM method (90.45%). In 
11_Tumors, the IPRC with gene pre-selection performs 
(96.18%) slightly less than the RPCA+LDA+SVM method 
(99.34%), that is, IPRC achieves competitive effect 
although combined with simple gene pre-selection 
method on multi-category dataset. 
3.5 Analysis of Candidate’s Pathogenic Genes 
Apart from obtaining high classification accuracy results, 
it is also important to identify pathogenicity-related genes, 
which can be a biomarker of early diagnosis and be 
helpful to auxiliary diagnosis. 
As shown in Subsection 3.4, candidate’s pathogenic 
genes can be selected by the two-stage hybrid gene 
selection method based on different penalty levels of 
logistic regression with LASSO. Firstly, the curve of 
appearance times versus gene index number is plotted by 
adjusting the penalty level   in LASSO-logistic 
regression. Fig. 16 illustrates the correlation between 
every gene and Colon tumor in a degree. Therefore, it can 
be conjectured that the more it occurs, the more relevant 
with tumor it is. Then the candidate pathogenic subset 
contains the genes, which occur more than a threshold 
value (here, 13 times). At last, the intersection genes over 
the threshold value are selected as the candidate 
pathogenic gene subset. 
Some genes from the final candidate subset for Colon 
data are shown in Table 7, which are believed to be 
closely related to Colon cancer. Gene H08393 has been 
turned out to be associated with Colon cancer in clinical 
[43-44]. For further illustration, the related function of 
these genes is searched in NCBI dataset. For instance, 
Collagen 11, a heterotrimeric molecule consisting of 1 , 
2  and 3  chains have role in formation of collagen 
TABLE 6 
CLASSIFICATION ACCURACIES OF OUR METHOD WITH DIFFERENT 
SELECTION STAGES 
Datasets Selection methods 
Original LASSO First stage Two stage 
Colon 88.81 90.95(978) 90.95(389) 91.90(143) 
DLBCL 89.82 92.32(2002) 94.82(828) 96.07(270) 
 
 
 (a)                (b)                (c) 
Fig. 15. Representation of all samples consisting of 40 tumor (stars) 
and 22 normal (squares) on Colon datasets. the top three 
components of (a) original genes, (b) pre-selected genes and (c) 
two-stage hybrid selected genes. 
 
Fig. 16. Number of occurrences versus gene index number on 
Colon dataset. In general, the more times it occurs, the more 
important the gene is. The line expresses the threshold of occur 
frequency. 
  TABLE 7 
LIST OF THE BEST SUBSET OF SOME GENES FOR COLON 
DATASET 
Index no.of 
selectedgenes 
Gene accession 
number Gene description 
493 R87126 Myosin heavy chainonmuscle (Gallus gallus) 
1772 H08393 Collagen (XI) chain (Homo sapiens) 
249 M63391 Human desmin genecomplete cds. 
625 X12671 
Human gene for heterogeneous nuclear 
ribonucleoprotein (hnRNP) core protein 
66 T71025 Human (HUMAN);mRNA sequence 
1873 L07648 Human MXI1 mRNA,complete cds. 
897 H43887 Complement factor D precursor 
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fibrils. 11 1COL A , a gene for collagen (H08393), which is 
normally not expressed in adult colon tissue, has been 
found to be expressed in colorectal carcinomas. Another 
collagen gene, COL5A2, normally not expresses but has 
been found co-expressed with COL11A1 in tumors. 
HNRNPA1 gene (X12671) encodes a member of a family 
of ubiquitously expressed heterogeneous nuclear 
ribonucleoproteins (hnRNPs), which are RNA-binding 
proteins that associate with pre-mRNAs in the nucleus 
and influence pre-mRNA processing, as well as other 
aspects of mRNA metabolism and transport. The protein 
encoded by this gene is one of the most abundant core 
proteins of hnRNP complexes and plays a key role in the 
regulation of alternative splicing. Quantitative alteration 
of hnRNPA1 may result in facilitation of transformation 
of colon epithelial cells as a consequence of 
transcriptional and translational perturbation. Desmin 
gene (M63391) encodes a muscle-specific category III 
intermediate filament. Homopolymers of this protein 
form a stable intracytoplasmic filamentous network 
connecting myofibrils to each other and to the plasma 
membrane. Mutations in this gene are associated with 
desmin-related myopathy, a familial cardiac and skeletal 
myopathy (CSM), and with distal myopathies. 
In order to check the quality of the selection processes, 
the expression profiles of the final identified genes for the 
opposite category are analyzed. For comparison, an 
irrelevant gene chosen randomly is presented. In Fig. 17, 
the curve with star denotes gene expression levels of 40 
tumor samples and the curve with square expresses gene 
expression levels of 22 normal samples. The line indicates 
the mean values of gene expression levels in 
corresponding class. One can see in both cases the mean 
value of the samples belonging to tumor category differs 
significantly from the referenced (normal) category. Fig. 
18 shows the image of the expression profiles for the two 
pathogenic genes (H08393 and X12671) and two irrelative 
genes (M22488 and R72644) in the form of the colormap 
of jet, where transition from small value to high value 
corresponds to a shift from low to high expression values 
of the samples. The vertical axis represents samples (20 
tumor samples, 10 normal samples) and the horizontal 
the genes arranged by index number 1772, 625, 1122, and 
1408 respectively. Fig. 18 demonstrate that moderate to 
high upregulation of H08393 and X12671 and 
downregulation for other two genes can indicate the 
presence of Colon. There is a visible difference between 
samples of the Colon tumor group and the reference one 
in H08393 and X12671 but similar expression levels in 
M22488 and R72644, which confirms good performance of 
the proposed gene selection procedure. 
To further study the biological function of the 
candidate pathogenicity-related genes, we also perform 
the functional enrichment analysis of the top 178 genes 
identified by our method on the website 
https://david.ncifcrf.gov/. The results of 
KEEG_PATHWAY are listed in Table 8. It can be seen 
from this table that the item of DNA replication has the 
lowest p-value, so it is considered as the most probable 
enrichment item. Some other items with the most 
significance are also listed in this table, for example, the 
first five pathways have statistical meaning ( 0.05p ). For 
genes enrich in these pathways, we further do 
Kaplan-Meier curve by anglicizing survival curves and 
corresponding Log-Rank P  values. We have found two 
proto-oncogenes (NCBP2 with 0.0217P  and ITGA7 
with  0.0183P ) and one anti-oncogene (TPM1 with 
0.0197P ). Fig. 19 shows that, for proto-oncogenes and 
anti-oncogene, high expression and low expression have 
 
Fig. 18. Heat map of the samples for the Colon dataset. Each panel 
corresponds to one gene. From small to high values represents low 
to high expression levels of samples. The image reveals that 
moderate to high upregulation of H08393 and X12671 and 
downregulation for other two irrelative genes (M22488 and R72644).
 
Fig. 17. Comparison of expression levels for the pathogenic genes 
(left) and irrelevant genes (right). For pathogenic genes H08393, 
the mean and standard deviation of expression levels about tumor 
category samples are higher than that of normal category samples. 
But for irrelevant genes M22488, there are similar mean and std in 
both categories. 
 
TABLE 8 
THE KEEG PATHWAY TERMS ENRICHMENT ANALYSIS OF THE TOP 178 
GENES IN THE COLON DATA SET BY DAVID 
Rank KEEG-PATHWAY P-value 
1 DNA replication 5.7E-3 
2 Spliceosome 8.8E-3 
3 Hypertrophic cardiomyopathy(HCM) 1.1E-2 
4 Dilated cardiomyopathy 1.4E-2 
5 Arrhythmogenogenic right ventricular 4.2E-2 
06 ECM-receptor interaction 5.4E-2 
7 Pyruvate metabolism 6.3E-2 
8 Aminoacy-tRNA biosynthesis 6.5E-2 
9 Purine metabolism 7.0E-2 
10 Pyrimidine metabolism 7.2E-2 
 
 
Fig. 19. Kaplan-Meier survival curves of genes which enrich in 
pathways with statistical meaning ( 0.05p ). Subimages from left to 
right: NCBP2 and TPM1 respectively.  lines with dotted arrow 
denote upper 50% percentile and lines with solid arrow denote lower 
50% percentile. 
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significant difference in survival rate. 
4 CONCLUSIONS AND FUTURE WORK 
In this paper, a simple, efficient and stable representation 
technique, IPRC, is presented for improving SRC by 
taking full advantages of test samples. For robust tumor 
classification, a two-stage hybrid gene selection algorithm 
is designed to combine with IPRC. Furthermore, some 
valuable analysis of candidate pathogenicity-related 
genes is given. 
There remain some interesting questions. One is how to 
enforce some prior constraints into the IPRC model based 
on different applications. Another is to seek more 
effective gene selection methods. 
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